2022 annual financial data
Aytu BioPharma 2022 Operating margin
Direct answer
Operating margin was -113.69%.
Operating income was -109,906,000 USD and net income was -108,779,000 USD.
Operating cash flow was -28,823,000 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 96,669,000 USD
- Operating income
- -109,906,000 USD
- Net income
- -108,779,000 USD
- Operating cash flow
- -28,823,000 USD